SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-023332
Filing Date
2022-08-17
Accepted
2022-08-17 16:15:46
Documents
13
Period of Report
2022-08-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 72529
  Complete submission text file 0001493152-22-023332.txt   246216

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abeo-20220817.xsd EX-101.SCH 2989
3 XBRL LABEL FILE abeo-20220817_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE abeo-20220817_pre.xml EX-101.PRE 22379
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3609
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 221174208
SIC: 2834 Pharmaceutical Preparations